Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
AbbVie (DE:4AB)
XETRA:4AB
Holding DE:4AB?
Track your performance easily
4AB Analyst Ratings
Moderate Buy
14 Buy
6 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
4AB Stock 12 Month Forecast
Average Price Target
€193.95
▲(14.57% Upside)
| Highest Price Target€217.84 | Average Price Target€193.95 | Lowest Price Target€158.34 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
Evercore ISI
Reiterated
01/30/25
Bank of America Securities
Assigned
01/28/25
Citi
Reiterated
01/28/25
Raymond James
Reiterated
01/28/25
Goldman Sachs
Reiterated
01/27/25
Piper Sandler
Assigned
01/27/25
Morgan Stanley
Reiterated
01/24/25
Wells Fargo
Reiterated
01/22/25
Berenberg Bank
Reiterated
01/21/25
Guggenheim
€212.08→€203.44
Buy
20.18%
Upside
Reiterated
01/17/25
AbbVie price target lowered to $212 from $221 at GuggenheimAbbVie price target lowered to $212 from $221 at Guggenheim
BMO Capital
€199.6
Buy
17.91%
Upside
Reiterated
01/16/25
BMO Capital reiterates Outperform Rating on Abbvie (ABBV) as II Portfolio Sees New Avenues for Growth in 2025BMO Capital analyst Evan David Seigerman reiterated an Outperform rating and $208.00 price target on Abbvie (NYSE: ABBV).
Leerink Partners
―
Buy
―
Reiterated
01/15/25
Optimistic Outlook on AbbVie's Emraclidine Strategy: A High-Reward Investment Opportunity
Truist Financial
€206.32→€202.48
Buy
19.61%
Upside
Reiterated
01/07/25
Truist Financial Sticks to Its Buy Rating for AbbVie (ABBV)
TD Cowen
€215.92
Buy
27.55%
Upside
Assigned
12/10/24
AbbVie: Strong Buy Rating Based on Growth Potential and Strategic Positioning
Best Analysts Covering AbbVie
Which Analyst Should I Follow If I Want to Buy DE:4AB and Sell After:
1 Month
xxx
Success Rate
15/24 ratings generated profit
Average Return
+2.33%
reiterated a xxx
rating 4 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 62.50% of your transactions generating a profit, with an average return of +2.33% per trade.
3 Months
xxx
Success Rate
18/24 ratings generated profit
Average Return
+7.22%
assigned a xxx
rating 3 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 75.00% of your transactions generating a profit, with an average return of +7.22% per trade.
1 Year
Success Rate
15/17 ratings generated profit
Average Return
+13.67%
reiterated a buy rating 10 days ago
Copying Mohit Bansal's trades and holding each position for 1 Year would result in 88.24% of your transactions generating a profit, with an average return of +13.67% per trade.
2 Years
xxx
Success Rate
24/24 ratings generated profit
Average Return
+31.13%
reiterated a xxx
rating 4 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +31.13% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
4AB Analyst Recommendation Trends
Rating
Sep 24
Oct 24
Nov 24
Dec 24
Jan 25
Strong Buy
0
0
0
0
0
Buy
21
19
30
31
29
Hold
9
12
15
14
12
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
30
31
45
45
41
Each month's total comprises the sum of three months' worth of ratings.
4AB Financial Forecast
4AB Stock Forecast FAQ
What is DE:4AB’s average 12-month price target, according to analysts?
Based on analyst ratings, AbbVie’s 12-month average price target is €193.95.
What is DE:4AB’s upside potential, based on the analysts’ average price target?
AbbVie has 14.57% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is AbbVie a Buy, Sell or Hold?
AbbVie has a consensus rating of Moderate Buy, which is based on 14 buy ratings, 6 hold ratings and 0 sell ratings.
What is AbbVie’s share price target?
The average share price target for AbbVie is €193.95. This is based on 20 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is €217.84 ,and the lowest forecast is €158.34. The average share price target represents 14.57% Increase from the current price of €169.28.
The highest analyst share price target is €217.84 ,and the lowest forecast is €158.34. The average share price target represents 14.57% Increase from the current price of €169.28.
What do analysts say about AbbVie?
AbbVie’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 20 Wall Streets Analysts.
How can I buy shares of AbbVie?
To buy shares of DE:4AB, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.